Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to lidocaine for Bier block in upper extremity surgery
IRCT20220513054842N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and lidocaine in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Onset of anesthesia and Duration of anesthesia. Started Nov 2024; status: completed.
02
Drugs
dexmedetomidinelidocaine
Beyond the preview
Go deeper on IRCT20220513054842N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220513054842N3.